2007
DOI: 10.1016/j.neulet.2007.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(24 citation statements)
references
References 45 publications
0
23
1
Order By: Relevance
“…Similarly, TFAM transgenic mice are protected from age-dependent memory impairment and mitochondrial DNA damage in brain microglia (Hayashi et al, 2008). Of note, a TFAM genetic variant has been associated with Alzheimer’s disease in several populations (Belin et al, 2007; Bertram et al, 2007). The published results together with our findings strongly implicate TFAM in the preservation of mitochondrial function.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, TFAM transgenic mice are protected from age-dependent memory impairment and mitochondrial DNA damage in brain microglia (Hayashi et al, 2008). Of note, a TFAM genetic variant has been associated with Alzheimer’s disease in several populations (Belin et al, 2007; Bertram et al, 2007). The published results together with our findings strongly implicate TFAM in the preservation of mitochondrial function.…”
Section: Discussionmentioning
confidence: 99%
“…Organ-targeted depletion of TFAM has substantiated the importance of mitochondrial metabolism in various cell types, including cardiomyocytes and β-cells (Larsson and Rustin, 2001; Silva et al, 2000). Furthermore, mitochondrial dysfunction accelerates biological aging and a polymorphism in the tfam gene has been associated with familial Alzheimer’s disease (Belin et al, 2007). Conversely, mice overexpressing TFAM are protected from age-dependent impairment of brain performance by preserving mitochondrial function in microglia (Hayashi et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…To date, there are no confirmed TFAM clinical mutations, although the genetic variant rs2306604 may be linked to Alzheimer’s disease (Belin et al, 2007) pending more comprehensive clinical and biochemical analyses. However, TFAM has shown promise for being an anti-aging therapeutic agent.…”
Section: Age-related Mitochondrial Diseases Associated With Defectmentioning
confidence: 99%
“…Recent studies suggest particular TOMM40 polymorphisms may affect the age of AD onset more stringently than APOE polymorphisms, leading some to speculate this mitochondrial protein is potentially more relevant to AD than apolipoprotein E (223). Several studies have also associated variation in the TFAM gene with AD risk (5,14,102,303). The TFAM gene encodes transcription factor A of the mitochondria, which plays a major role in mtDNA replication and expression (50, 82,134,200).…”
Section: Synthesizing the Data: The Mitochondrial Cascade Hypothesismentioning
confidence: 99%